Illumina (ILMN) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4523271090

Illumina, Inc. is a company that focuses on providing advanced sequencing- and array-based solutions for genetic and genomic analysis. These solutions are utilized not only in the United States but also in countries like Singapore and the United Kingdom. The company operates through two main segments - Core Illumina and GRAIL.

Customers can rely on Illumina for a range of products including sequencing and array-based instruments, consumables like reagents and flow cells, whole-genome sequencing kits, and targeted resequencing kits. Additionally, Illumina offers services such as whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services, along with an innovative multi-cancer early detection test called Galleri.

Furthermore, Illumina is dedicated to developing solutions that aim to expedite cancer diagnoses, enhance blood-based detection for minimal residual disease, and pioneer various post-diagnostic applications. The company caters to a broad customer base including genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.

Established in 1998 and headquartered in San Diego, California, Illumina, Inc. actively collaborates with industry partners such as Myriad Genetics to expand access to HRD testing. To learn more about Illumina and its offerings, visit their website at

AI improved, may contain errors or wrong assumptions

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Illumina (ILMN) - Stock Price & Dividends

ILMN Stock Overview

Market Cap in USD 22,254m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 2000-07-28

ILMN Stock Ratings

Fundamental -1.03
Dividend -
Growth 5y -4.54
Rel. Performance vs Sector -5.12
Analysts 3.67
Fair Price Total Ret. 129.23
Fair Price DCF 48.81

ILMN Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

ILMN Growth Ratios

Growth 12m -29.84%
Growth Correlation 12m -65%
Growth Correlation 3m 51%
CAGR 5y -15.31%
CAGR / Mean Drawdown -0.45
Sharpe Ratio 12m -0.78
Alpha vs SP500 12m -61.32
Beta vs SP500 5y weekly 1.07
CAPM 8.18%
Average Daily Range 2m 3.70%
Regime Oscillator 57.71
Volatility GJR Garch 1y 48.38%
Price / SMA 50 0.71%
Price / SMA 200 -8.61%
Current Volume 1322.8k
Average Volume 20d 1840.8k

External Links for ILMN Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of ILMN stocks?
As of February 28, 2024, the stock is trading at USD 139.76 with a total of 1,322,847 shares traded.
Over the past week, the price has changed by -0.21%, over one month by -0.62%, over three months by +47.66% and over the past year by -29.02%.
Why is ILMN stock down?
Check with which Index or Commodity ILMN has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return ILMN Return S&P 500
1 Month -0.62% 4.00%
3 Months 47.66% 11.99%
12 Months -29.02% 29.39%
What is the forecast for ILMN stock price target?
According to ValueRays Forecast Model, ILMN Illumina will be worth about 143.7 in February 2025. The stock is currently trading at 139.76. This means that the stock has a potential upside of +2.84%.
Issuer Forecast Upside
Wallstreet Target Price 152.8 9.3%
Analysts Target Price 186.4 33.4%
ValueRay Target Price 143.7 2.8%